These results suggest that SUCLG2 plays a crucial role in regulating lactate metabolism and participates in the metabolic reprogramming of GBM, potentially inhibiting the progression of GBM by affecting DLAT expression and acetyl-CoA production. The gene discussed is SUCLG2; the disease is glioblastoma.